Preoperative statin use and infection after cardiac surgery: A cohort study

Clinical Infectious Diseases

Volumn 48, Issue 7, 2009, Pages

  Mohamed, Rachid ^a   McAlister, Finlay A ^a,e   Pretorius, Victor ^b   Kapoor, Anmol S ^d   Majumdar, Sumit R ^a   Ross, David B ^b   Norris, Colleen M ^b,c,d  

^a Division of General Internal Medicine   (Canada)

^b Division of Cardiovascular Surgery   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATORVASTATIN; CEFALEXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENICILLIN G; PRAVASTATIN; SIMVASTATIN; VANCOMYCIN;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; CHEMOPREVENTION; COHORT STUDIES; FEMALE; HEPTANOIC ACIDS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PRAVASTATIN; PROSPECTIVE STUDIES; PYRROLES; SIMVASTATIN; SURGICAL WOUND INFECTION; THORACIC SURGERY; TREATMENT OUTCOME;

EID: 63649149533     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597300     Document Type: Article

References (25)

1. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006;367:413-8.
2. Brull DJ, Sanders J, Montgomery HE, et al. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol 2001;88:431-3.
3. Haldar K. Targeting the host to control an infection disorder. Arch Intern Med 2008; 168:2067-8.
4. Chua D, Tsang S, Kuo IF. Role of statin therapy in sepsis. Ann Pharmacother 2007;41:647-52.
5. Majumdar SR, McAlister FA, Eurich DT, Padwal R, Marrie TJ. Statins and outcomes in patients admitted to hospital with community-acquired pneumonia: population-based prospective cohort study. BMJ 2006;333:999-1002.
6. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother 2008;61:774-85.
7. Coleman CI, Lucek DM, Hammond J, Michael C. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin 2007;23:1783-90.
8. Kapoor A, Kanji H, Buckingham J, Devereaux PI, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006; 333: 1149-52.
9. Ghali WA, Knudtson ML. Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. Can J Cardiol 2000;16:1225- 30.
10. Mamdani M, Tu JV. Did the major clinical trials of statins affect prescribing behaviour? CMAJ 2001;164:1695-6.
11. Gravel D, Taylor G, Ofner M, et al; The Canadian Nosocomial Infection Surveillance Program. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007;66:243-8.
12. Hassan M, Smith IM, Engel AM. Predictors and outcomes of sternal wound complications in patients after coronary artery bypass graft surgery. Am Surg 2006;72:515-20.
13. Topkara VK, Cheema FH, Kesavaramanujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005;112(Suppl 9)4344-50.
14. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006;113:1063-70.
15. Thomsen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia: a population based cohort study. Crit Care Med 2006;34:1080-6.
16. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004; 110(11 Suppl 1) II45-9.
17. Dotani MI, Elnicki DM, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000;86:1128-30.
18. Feringa HHH, Schouten O, Karagiannis SE, et al. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 2007;50:1649-56.
19. Ali IS, Buth KJ. Preoperative statin use and outcomes following cardiac surgery. Int J Cardiol 2005;103:12-18.
20. Collard CD, Body SC, Shernan SK, et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2006;132:392-400.
21. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114:1455-61.
22. Barrett TW, Mori M, Koudelka C. Perioperative beta-blockers, but not statins, are associated with decreased short term mortality after vascular surgery [abstract 173162]. J Gen Intern Med 2007;22(Suppl 1):76.
23. Farrokhyar F, Wang X, Kent R, Lamy A. Early mortality from off-pump and on-pump coronary bypass surgery in Canada: a comparison of the STS and the Euroscore risk prediction algorithms. Can J Cardiol 2007;23:879-83.
24. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999; 15:394-400.
25. Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome: a metaanalysis of randomized controlled trials. Arch Intern Med 2006; 166: 1814-21.